Zdrowie i gospodarka · 28/11/2006
FDA to Host Public Meeting on Enhancing Container Labeling for Parenteral Infusion Drug Products
The FDA is hosting a public meeting to discuss improving patient safety by enhancing the labeling of intravenous drug products, with the goal of minimizing medication errors.
Source: Federal Register — Food and Drug AdministrationOpen original release →